As I just mentioned, you will be analyzing DNA sequences that are 15,000 nucleotides long.
ABC News also has dibs on Father Greeley, while Mr. Kaiser will be analyzing the proceedings for CBS News.
The Phase I and II results will be analyzed primarily through descriptive methods.
Statistical analysis will be performed according to the intention-to-treat principle; i.e. patients will be analyzed in the treatment group to which they were randomly allocated.
The four conformations sets were then refined in water and, for (ii) and (iii), in the presence of NCS restraints, to provide the sets w_exact_xray, wNCS_nmr_xray, wNCS_nmrI and wNCS_nmrII, which will be analyzed in more details below.
To determine if differences exist between groups after adjusting for potential confounding variables, such as age, gender, comorbidity, etc. or imbalances between groups, unplanned healthcare utilization (i.e., visits/admissions) will be analyzed using Poisson regression models.
Other variables (i.e. IIQ) will be analyzed similarly.
All analyses will be conducted using intention to treat, i.e., each individual will be analyzed in the group to which he or she was initially allocated, independent of dropouts from the intervention group or any beginning of physical activity among members of the control group.
The data will be organized into two levels using a multilevel structure, i.e., individuals and municipalities, which will be analyzed using linear mixed-effects models.
Study participants will be analyzed as randomized (i.e., "intention to treat") regardless of subsequent intervention adherence.
